REG-EVRAZ plc EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective

EvrazAnnouncement

28/12/2022 07:45

============

   EVRAZ plc (EVR)
   EVRAZ plc announces that the Appointment and the Amendments adopted as
   part of the Consent Solicitation for its outstanding U.S.$700,000,000
   5.250 per cent. notes due 2024 have become effective

   28-Dec-2022 / 10:30 MSK
   Dissemination of a Regulatory Announcement, transmitted by EQS Group.
   The issuer is solely responsible for the content of this announcement.

   ══════════════════════════════════════════════════════════════════════════

   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY  PERSON
   LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO  RELEASE,
   PUBLISH OR  DISTRIBUTE  THIS  ANNOUNCEMENT  OR  THE  CONSENT  SOLICITATION
   MEMORANDUM.

   EVRAZ plc announces  that the  Appointment and the  Amendments adopted  as
   part of  the Consent  Solicitation  for its  outstanding  U.S.$700,000,000
   5.250 per cent. notes due 2024 have become effective

   London, 28 December 2022 – on  15 November 2022, EVRAZ plc (the  “Issuer”)
   announced  a  consent   solicitation  in  relation   to  the   outstanding
   U.S.$700,000,000 5.250  per cent.  notes  due 2024  issued by  the  Issuer
   (Regulation S Notes: Common Coder 184344327 / ISIN XS1843443273; Rule 144A
   Notes: Common Code  111730776 / ISIN  US30052KAA79/ CUSIP 30052KAA7)  (the
   “Notes”) on  the terms  and subject  to the  conditions set  forth in  the
   consent solicitation  memorandum  dated  15 November  2022  (the  “Consent
   Solicitation Memorandum”). Capitalised terms used, but not defined herein,
   shall have  the  meanings  given  to  them  in  the  Consent  Solicitation
   Memorandum.

   The Issuer notifies that, on 23 December 2022, (i) the Issuer and the  New
   Trustee  entered  into   the  Deed  of   Appointment  to  effectuate   the
   Appointment; and  (ii) the Issuer  and the  New Trustee  entered into  the
   Supplemental Trust  Deed to  effectuate the  Amendments. Accordingly,  the
   Appointment and the Amendments  have become effective  and binding on  all
   Noteholders with effect from that date.

   The  Issuer  extends  its  gratitude  for  the  support  and   cooperation
   demonstrated by  investors  which has  been  reflected in  the  successful
   results of the Consent Solicitation.

    

    

   Questions and  requests  for assistance  in  connection with  the  Consent
   Solicitation should be directed to the Information and Tabulation Agent:

   Limited liability company “Legal Capital Investor Services”

   Address:  10 Krivokolenny lane, bldg. 6, Moscow 101000, Russia

   Email:    1 evraz@lcpis.ru

   Phone:   +7 495 122 05 17

   Website:   2 www.lcpis.ru

    

                                      ###

   For further information:

    

   Investor Relations

   +7 495 232 1370

   ir@evraz.com

    

   ══════════════════════════════════════════════════════════════════════════

   ISIN:           GB00B71N6K86, XS1533915721, XS1843443273,
   Category Code:  MSCL
   TIDM:           EVR
   LEI Code:       5493005B7DAN39RXLK23
   OAM Categories: 3.1. Additional regulated information required to be
                   disclosed under the laws of a Member State
   Sequence No.:   211143
   EQS News ID:    1521415


    
   End of Announcement EQS News Service

   ══════════════════════════════════════════════════════════════════════════

    3 fncls.ssp?fn=show_t_gif&application_id=1521415&application_name=news&site_id=reuters9

References

   Visible links
   1. mailto:evraz@lcpis.ru
   2. https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=aca9a1d187ca3d886cab87c02982d6e3&application_id=1521415&site_id=reuters9&application_name=news


============